Notice: Undefined offset: 1 in /var/www/jopcr.com/article-detail-page.php on line 103
Molecular Docking Study of Five Aromatic and Heteroaromatic Scaffolds for Assessing the Anticancer Activity by Comparison Against Imatinib
 
  • P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Molecular Docking Study of Five Aromatic and Heteroaromatic Scaffolds for Assessing the Anticancer Activity by Comparison Against Imatinib
  • VIEWS 19
  • PDF 7

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v24.i3.107

Year: 2025, Volume: 24, Issue: 3, Pages: 175–178

Original Article

Molecular Docking Study of Five Aromatic and Heteroaromatic Scaffolds for Assessing the Anticancer Activity by Comparison Against Imatinib

Thomas Kurian1,∗, Rani Sebastian2

1Associate Professor, College of Pharmacy, Government Medical College, Alappuzha, Kerala, India
2Assistant Professor, College of Pharmacy, Government Medical College, Kottayam, Kerala, India

*Corresponding Author
Email: thomaskurian54@gmail.com

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Heterocyclic compounds are important in biology and chemistry. Their therapeutic, chemical, and physical characteristics are distinct. A computer simulation method called molecular docking is used to identify potential drug candidates that can attach to a protein's active site. This study examined the anticancer properties of five heterocyclic compounds using molecular docking with PyRX 0.8 and MZ dock software. The primary focus was on the co-crystallized human cyclin-dependent kinase 2 (cdk2) complex with the oncoprotein PDGFRA 6JQI and receptor 3EZV, CDK-2 with indazole inhibitor nine bound at its active site. The toxicity of the lead molecule was also assessed using PROTOX 0.3 software. SWISS ADME software computed bioavailability and confirmed the results. According to the findings, ligands like ethyl 2,3-dihydro-1h-indole-2-carboxylate, (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl) methyl] phenyl]-6-methylsulfanyloxane-3,4,5-triol were identified as promising candidates and were validated against the well-known drug imatinib. The SWISS ADME data showed that the selected lead compounds had favourable ADME profiles. Despite the need for more research, these results imply that the lead compounds might be valuable additions to medicine. The safety and effectiveness of these heterocyclic compounds as possible therapeutic agents require more investigation, especially in vivo studies.

Keywords: In-silico, Cancer, Heteroaromatic, Aromatic, MZ-DOCK

References

  1. Ansardamavandi A, Tafazzoli-Shadpour M, Omidvar R, Jahanzad I. Quantification of effects of cancer on elastic properties of breast tissue by Atomic Force Microscopy. Journal of the Mechanical Behavior of Biomedical Materials. 2016;60:234–242. Available from: https://dx.doi.org/10.1016/j.jmbbm.2015.12.028
  2. Premnath D, Indiraleka M, Selvakumar PM, Enoch IVMV. Design, synthesis, spectral analysis and molecular docking studies of some fluorescent biodiagnostic material as potential anti cervical cancer agents. Materials Today: Proceedings. 2021;47:776–783. Available from: https://dx.doi.org/10.1016/j.matpr.2020.07.397
  4. Ronson TO, Taylor RJK, Fairlamb IJS. Palladium-catalysed macrocyclisations in the total synthesis of natural products. Tetrahedron. 2015;71(7):989–1009. Available from: https://dx.doi.org/10.1016/j.tet.2014.11.009
  5. Amr AEGE, Abo-Ghalia MH, Moustafa GO, Al-Omar MA, Nossier ES, Elsayed EA. Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors. Molecules. 2018;23(10):2416. Available from: https://dx.doi.org/10.3390/molecules23102416
  7. Dallakyan S, Olson AJ. Small-Molecule Library Screening by Docking with PyRx. Methods in Molecular Biology (Clifton, N.J.). 2015;1263:243–250. Available from: https://doi.org/10.1007/978-1-4939-2269-7_19
  11. Kabier M, Gambacorta N, Trisciuzzi D, Kumar S, Nicolotti O, Mathew B. MzDOCK: A free ready‐to‐use GUI‐based pipeline for molecular docking simulations. Journal of Computational Chemistry. 2024;45(23):1980–1986. Available from: https://dx.doi.org/10.1002/jcc.27390
  14. Supandi, Yeni, Merdekawati F. In Silico Study of Pyrazolylaminoquinazoline Toxicity by Lazar, Protox, and Admet Predictor. Journal of Applied Pharmaceutical Science. 2018;8(9):119–129. Available from: https://doi.org/10.7324/JAPS.2018.8918
  15. Faruqi A, Patel P, Jain A. Enalapril. Treasure Island . StatPearls Publishing. 2024.
  17. Lima LM, Barbosa MLdC, DNdA, Barreiro EJ. Case Study on Receptor Tyrosine Kinases EGFR, VEGFR, and PDGFR. In: Proteinkinase Inhibitors , Topics in Medicinal Chemistry. (Vol. 36, pp. 155-201) Cham. Springer. 2020.

Copyright

© 2025 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 16 November 2025

Year: 2025, Volume: 24, Issue: 3


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.